Hummingbird Bioscience

Hummingbird Bioscience is a precision biotherapeutics company developing biologic medicines for hard-to-treat diseases. 

bird birds flying humingbirds
Biotech

Frazier arms Callio with $187M series A to fly Hummingbird's ADC

Frazier Life Sciences has launched Callio with $187 million in series A funds and a HER2-targeted dual-payload ADC that’s ready for the clinic.
James Waldron Mar 3, 2025 9:00am
parachute sunset paragliding chutes

Takeda taps new head of US oncology business—Chutes & Ladders

Aug 2, 2024 8:30am
Diverse group of hands holding up US dollar banknotes of various denominations on green background - stock photo

Fibrosis-focused Endeavor bags $132.5M series C

Apr 24, 2024 7:30am
bird birds flying humingbirds

Endeavor signs $430M deal for Hummingbird's HER3-targeted ADC

Oct 19, 2023 10:29am
Singapore

20 years in, Singapore still searches for its biotech success story

Aug 6, 2023 8:00pm
pile of cash piggy bank money cash dollars bills spend

Amgen piles $2B more into pharma's ADC rush

Jan 5, 2023 10:20am